Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;6(1):19-28.
doi: 10.4161/21505594.2014.979692.

Brucella CβG induces a dual pro- and anti-inflammatory response leading to a transient neutrophil recruitment

Affiliations

Brucella CβG induces a dual pro- and anti-inflammatory response leading to a transient neutrophil recruitment

Clara Degos et al. Virulence. 2015.

Abstract

Brucella is the causing agent of a chronic zoonosis called brucellosis. The Brucella β-1,2 cyclic glucan (CβG) is a virulence factor, which has been described as a potent immune stimulator, albeit with no toxicity for cells and animals. We first used a genome-wide approach to characterize human myeloid dendritic cell (mDC) responses to CβG. Transcripts related to inflammation (IL-6, IL2RA, PTGS2), chemokine (CXCR7, CXCL2) and anti-inflammatory pathways (TNFAIP6, SOCS3) were highly expressed in CβG-treated mDC. In mouse GMCSF-derived DC, CβG triggered the expression of both activation (CXCL2, KC) and inhibition (SOCS3 and TNFAIP6) molecules. We then characterized the inflammatory infiltrates at the level of mouse ear when injected with CβG or LPS. CβG yielded a lower and transient recruitment of neutrophils compared to LPS. The consequence of these dual pro- and anti-inflammatory signals triggered by CβG corresponds to the induction of a controlled local inflammation.

Keywords: Brucella; CβG, Beta-1,2 cyclic glucan; DC, dendritic cells; E. coli, Escherichia coli; LPS, lipopolysaccharide; cyclic β glucan; inflammation; lipopolysaccharide; neutrophil.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Transcriptional profiling of human blood mDC from healthy donors stimulated with CβG (n = 5) or LPS (n = 4), respectively.(A) Heatmap representing the transcriptional expression levels of 15 regulatory genes differentially expressed between CβG and medium control (Welch T-test, P < 0.05). Data are normalized to the 6 h medium control for each donor. (B) Heatmap representing the transcriptional expression levels of 18 chemokines differentially expressed in mDc treated with CβG, LPS or cell culture medium. (C) Barcharts representing the raw expression value of CXCL2, IL8, PTGS2, SOCS3 and TNFAIP6 for the average of the 4 donors. Error bars represent the standard deviation. Ordinary one-way ANOVA with Tukey post-hoc test was conducted (***: P < 0.001; **: P < 0.01; *: P < 0.05; n.s: not significant).
Figure 2
Figure 2
(See previous page). Induction of gene expression in murine DC stimulated with Brucella CβG or E. coli LPS. (A) Murine BMDC were stimulated for 8 h and 24 h with E. coli LPS (black bars) or Brucella CβG (gray bars). mRNA was extracted from stimulated cells and qPCR performed to determine transcript expression levels of CXCL2, KC and PTGS2. Fold-increases were estimated by comparing with cells that had been stimulated with PBS as a negative control. Basal expression levels for each gene are indicated (dash line). HPRT was used as a housekeeping gene to normalize the data. An induction level of more than 2 is considered as significant. Mean ± standard deviation of 3 independent experiments is represented here. Mann-Whitney test, one-tailed (analysis on GraphPad Prism) has been done and P < 0.05 is denoted by “*."(B) Expression levels of SOCS3 and TNFAIP6 mRNA were assessed. Experiments were processed as described above. Three independent experiments were carried out. An induction level of more than 2 is considered as significant. Mean ± standard deviation of 3 independent experiments is represented here. (C) BMDC stimulated for 8 h or 24 h with PBS (control), E. coli LPS or Brucella CβG were lysed and protein purified. The expression of tsg-6 protein was assessed by western blot using 10 μg of recombinant tsg-6 as a positive control. β-actin expression was used as control. At least 3 independent experiments were carried out and one representative is shown here.
Figure 3.
Figure 3.
Brucella CβG induces the recruitment of CD11b+, LyG6+, and Gr1+ cells at the site on injection. (A) Mouse ears intradermally injected with PBS, E. coli LPS or Brucella CβG were recovered at 48 h post-injection and stained for hematoxylin and eosin. (B) Mouse ears injected with PBS, E. coli LPS or Brucella CβG were recovered at 48 h post-injection, embedded in tissueteck OCT compound and frozen in isopentan. 15 μm thick cryosections were then stained with CD11b (blue), Gr1 (red), Ly6G (green) and DAPI (gray) before observation under a Zeiss LSM 510. Bar: 0.25 mm.
Figure 4.
Figure 4.
Brucella CβG induces a transient neutrophil recruitment at 12 h post-injection. (A) Cells were extracted from mouse ears at 2 h, 6 h, 12 h, 24 h and 48 h following injection with PBS (white bars), E. coli LPS (black bars) or Brucella CβG (gray bars) (see Fig. 3) and neutrophils were quantified by flow cytometry. Mean ± SD of 3 independent experiments is represented here, Mann-Whitney test, one-tailed (analysis on GraphPad Prism) has been done and P < 0.05 is denoted by “*."(B) Dot-plots of neutrophil recruitment to the ear at 12 h post-injection with PBS, E. coli LPS or CβG. Cells were gated on CD45+, MHC II, CD11b+, Ly6C+. Neutrophils represented in blue population are negative for F4/80 and positive for Ly6G. (C) Dot-plots of neutrophil recruitment to the ear at 24 h post-injection with PBS, E. coli LPS or CβG. Cells were gated on CD45+, MHC II, CD11b+ and Ly6C+. Neutrophils (in blue) are negative for F4/80 and positive for Ly6G. Three independent experiments were carried out, and one representative is shown here.

References

    1. Ian Maudlin SW-M. The Control of Neglected Zoonotic Diseases – A Route to Poverty Alleviation. Geneva: WHO, 2006.
    1. de Jong MF, Tsolis RM. Brucellosis and type IV secretion. Future Microbiol 2012; 7:47-58; PMID:22191446; http://dx.doi.org/10.2217/fmb.11.136 - DOI - PubMed
    1. Lacerda TL, Salcedo SP, Gorvel JP. Brucella T4SS: the VIP pass inside host cells. Curr Opin Microbiol 2013; 16:45-51; PMID:23318140; http://dx.doi.org/10.1016/j.mib.2012.11.005 - DOI - PubMed
    1. Salcedo SP, Marchesini MI, Lelouard H, Fugier E, Jolly G, Balor S, Muller A, Lapaque N, Demaria O, Alexopoulou L, et al. . Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathogens 2008; 4:e21; PMID:18266466; http://dx.doi.org/10.1371/journal.ppat.0040021 - DOI - PMC - PubMed
    1. Salcedo SP, Marchesini MI, Degos C, Terwagne M, Von Bargen K, Lepidi H, Herrmann CK, Santos Lacerda TL, Imbert PR, Pierre P, et al. . BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions. Front Cell Infect Microbiol 2013; 3:28; PMID:23847770; http://dx.doi.org/10.3389/fcimb.2013.00028 - DOI - PMC - PubMed

Publication types

MeSH terms